electroCore completes acquisition of neurotechnology solution provider NeuroMetrix
NeuroMetrix’s Quell platform is a cloud-enabled wearable neuromodulation solution intended to treat fibromyalgia symptoms.
| Ticker |
NURO
|
| CIK | 0001289850 |
| SIC | 3841 |
| Sector | Manufacturing |
| Industry Category | Medical Equipment |
| Industry Group | Surgical, Medical, And Dental Instruments And Supplies |
| Address | 1000 WINTER STREET, WALTHAM, MA, 02451 |
| Website | neurometrix.com |
| Phone | (781) 890-9989 |
| CEO | Shai N. Gozani |
| Employees | 20 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
electroCore completes acquisition of neurotechnology solution provider NeuroMetrixNeuroMetrix’s Quell platform is a cloud-enabled wearable neuromodulation solution intended to treat fibromyalgia symptoms. Here’s Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at where NeuroMetrix, Inc. (NASDAQ:NURO) stands against the other diabetes stocks. Global Growth and Innovation in Diabetes Care: The Rise of Continuous Glucose Monitors and AI Integration About 422 million people […] NeuroMetrix to be Acquired by electroCoreNeuroMetrix shareholders to receive cash and Contingent Value RightsWOBURN, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (“NeuroMetrix” or the “Company”) (Nasdaq: NURO) today announced it has entered into a definitive merger agreement whereby electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial stage bioelectronic medicine and wellness company, will acquire NeuroMetrix. The transaction has been unanimously approved by the Boards of Directors of both companies and is expec NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives GrowthDespite a 51% revenue dip, NURO narrowed losses in Q3 2024 by reducing operating expenses by 25%, offsetting the challenging revenue environment. NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023)NeuroMetrix ( NASDAQ:NURO ) Third Quarter 2024 Results Key Financial Results Revenue: US$587.3k (down 51% from 3Q... |